docetaxel anhydrous has been researched along with Injuries, Radiation in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (10.00) | 18.2507 |
| 2000's | 7 (35.00) | 29.6817 |
| 2010's | 9 (45.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guillerm, S; Hennequin, C; Quero, L | 1 |
| Fan, WJ; Lu, YP; Luo, YR; Ma, L; Teng, F; Yu, W; Zhang, Q | 1 |
| Dai, J; Li, J; Li, Y; Liu, N; Song, Y; Tang, X; Wu, Y; Xian, P; Xiong, L; Zhou, H | 1 |
| Hu, C; Li, Y; Lu, X; Qian, W; Xu, T | 1 |
| Chang, H; Deng, X; Ge, Y; Li, Y; Lu, L; OuYang, PY; Sheng, Y; Wu, JQ; Xie, T; Zhang, G | 1 |
| Ahn, SJ; Ban, HJ; Chung, WK; Kim, KS; Kim, YC; Kim, YI; Kwon, YS; Lim, SC; Nam, TK; Oh, IJ; Song, JY; Yoon, MS | 1 |
| Gomez, D; Komaki, R; Lee, MS; Levy, LB; Liao, Z; Lu, C; Tang, C; Zhuang, Y | 1 |
| Ahn, SJ; Ban, HJ; Chung, WK; Jeong, JU; Kim, KS; Kim, YC; Kim, YH; Nam, TK; Oh, IJ; Song, JY; Yoon, MS | 1 |
| Chen, L; Chen, NX; Ma, L; Wang, JL; Yan, F; Zhang, XX | 1 |
| Kubo, A; Mitsui, Y; Nakahara, T; Shigematsu, N; Takagi, Y; Takemasa, K; Tsuyuki, A | 1 |
| Choudhury, A; Clark, JI; Eisner, RM; Emami, B; Hofmeister, C; Lathers, D; Lau, A; Norton, J; Petruzzelli, G; Thomas, S; Young, MR | 1 |
| Guan, XY; Liu, YJ; Zhu, GP | 1 |
| Douzinas, EE; Giannakouras, G; Ioannidou, G; Katsilieris, I; Kritselis, G; Liossi, P; Rapidis, AD; Roupakia, A; Stavrinidis, E; Trichas, M | 1 |
| Asakura, H; Fuji, H; Harada, H; Mizumoto, M; Murayama, S; Nishimura, T; Zenda, S | 1 |
| Burkey, BB; Chen, C; Cmelak, AJ; Kane, MA; Kish, B; Murphy, BA; Netterville, JL; Raben, D; Shakhtour, B; Shyr, Y; Song, JI; Willey, CD | 1 |
| Ishikura, S; Mori, K; Nishiwaki, Y; Nokihara, H; Saijo, N; Sekine, I; Sumi, M; Tamura, T; Tsukiyama, I | 1 |
| Aapro, MS; Zulian, GB | 1 |
| Prescott, LM | 1 |
| Fleming, D; Hahl, M; Morkas, M | 1 |
1 review(s) available for docetaxel anhydrous and Injuries, Radiation
| Article | Year |
|---|---|
Combination of chemotherapy and radiotherapy: A thirty years evolution.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Chemoradiotherapy; Cisplatin; DNA Repair; Docetaxel; Drug Administration Schedule; Fluorouracil; Humans; Molecular Targeted Therapy; Neoplasms; Organs at Risk; Radiation Injuries; Time Factors | 2019 |
8 trial(s) available for docetaxel anhydrous and Injuries, Radiation
| Article | Year |
|---|---|
Diffusion-weighted imaging as a follow-up modality for evaluation of major salivary gland function in nasopharyngeal carcinoma patients: a preliminary study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Diffusion Magnetic Resonance Imaging; Docetaxel; Female; Follow-Up Studies; Humans; Lymphatic Irradiation; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Prospective Studies; Radiation Injuries; Radiotherapy, Intensity-Modulated; Salivary Glands; Salivation; Xerostomia; Young Adult | 2020 |
A phase III concurrent chemoradiotherapy trial with cisplatin and paclitaxel or docetaxel or gemcitabine in unresectable non-small cell lung cancer: KASLC 0401.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Prospective Studies; Radiation Injuries; Radiotherapy, Conformal; Survival Rate; Taxoids; Treatment Outcome | 2013 |
O02.03 Value of adding erlotinib to thoracic radiation therapy with chemotherapy for stage III non-small cell lung cancer: a prospective phase II study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Consolidation Chemotherapy; Disease-Free Survival; DNA Mutational Analysis; DNA, Neoplasm; Docetaxel; Erlotinib Hydrochloride; Esophagitis; Genes, erbB-1; Humans; Lung Neoplasms; Paclitaxel; Prospective Studies; Quinazolines; Radiation Injuries; Radiation Pneumonitis; Radiation-Sensitizing Agents; Radiotherapy Dosage; Survival Analysis; Taxoids | 2014 |
Phase I adjuvant radiation with docetaxel in high-risk head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Confidence Intervals; Docetaxel; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Probability; Prognosis; Prospective Studies; Radiation Injuries; Radiotherapy Dosage; Radiotherapy, Adjuvant; Radiotherapy, Intensity-Modulated; Risk Assessment; Survival Analysis; Taxoids; Treatment Outcome | 2009 |
Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
Topics: Adult; Age Distribution; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Radiation Injuries; Radiotherapy; Remission Induction; Sex Distribution; Survival Analysis; Taxoids; Treatment Outcome | 2006 |
Frequency and characteristics of docetaxel-induced radiation recall phenomenon.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Comorbidity; Docetaxel; Female; Humans; Incidence; Japan; Male; Middle Aged; Neoplasms; Radiation Injuries; Radiation Tolerance; Risk Assessment; Risk Factors; Taxoids | 2006 |
A Phase II multi-institutional trial of chemoradiation using weekly docetaxel and erythropoietin for high-risk postoperative head and neck cancer patients.
Topics: Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Dose Fractionation, Radiation; Erythropoietin; Female; Head and Neck Neoplasms; Hemoglobin A; Humans; Male; Middle Aged; Mouth Mucosa; Prospective Studies; Radiation Injuries; Radiation-Sensitizing Agents; Radiotherapy Dosage; Stomatitis; Taxoids | 2007 |
Docetaxel consolidation therapy following cisplatin, vinorelbine, and concurrent thoracic radiotherapy in patients with unresectable stage III non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Female; Humans; Lung Neoplasms; Male; Middle Aged; Radiation Injuries; Survival Rate; Taxoids; Vinblastine; Vinorelbine | 2006 |
11 other study(ies) available for docetaxel anhydrous and Injuries, Radiation
| Article | Year |
|---|---|
Efficacy and safety of Prostate stereotactic body radiotherapy for metastatic castration-resistant prostate cancer: A prospective cohort study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cystitis; Docetaxel; Dose Fractionation, Radiation; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Male; Neoplasm Grading; Orchiectomy; Proctitis; Progression-Free Survival; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radiation Injuries; Radiosurgery; Random Allocation; Survival Rate; Tumor Burden | 2021 |
Radiation-induced nasopharyngeal ulcers after intensity modulated radiotherapy in primary nasopharyngeal carcinoma patients: A dose-volume-outcome analysis.
Topics: Adult; Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Deoxycytidine; Docetaxel; Dose-Response Relationship, Radiation; Female; Fluorouracil; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Diseases; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Radiation Injuries; Radiotherapy Dosage; Radiotherapy, High-Energy; Radiotherapy, Intensity-Modulated; Retrospective Studies; Treatment Outcome; Ulcer | 2018 |
Temporal lobe injury patterns following intensity modulated radiotherapy in a large cohort of nasopharyngeal carcinoma patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Edema; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Incidence; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Necrosis; Radiation Injuries; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Retrospective Studies; Temporal Lobe | 2018 |
Effects of Chemotherapy Regimen and Radiation Modality on Hematologic Toxicities in Patients Receiving Definitive Platinum-based Doublet Chemoradiation for Non-Small Cell Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Docetaxel; Etoposide; Female; Hemoglobins; Humans; Leukopenia; Logistic Models; Lung Neoplasms; Lymphopenia; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Neutropenia; Paclitaxel; Proportional Hazards Models; Radiation Injuries; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Retrospective Studies; Severity of Illness Index; Survival Rate; Taxoids; Thrombocytopenia | 2017 |
Predictive factors for survival and correlation to toxicity in advanced Stage III non-small cell lung cancer patients with concurrent chemoradiation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Deoxycytidine; Docetaxel; Drug Administration Schedule; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Proportional Hazards Models; Radiation Injuries; Radiotherapy, Conformal; Retrospective Studies; Taxoids; Treatment Outcome | 2016 |
[Clinical analysis of multimodal treatment for orbital organ preservation in T4b squamous cell carcinoma of nasal cavity and paranasal sinuses].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; ErbB Receptors; Female; Fluorouracil; Humans; Induction Chemotherapy; Male; Middle Aged; Nasal Cavity; Nose Neoplasms; Organ Sparing Treatments; Paranasal Sinus Neoplasms; Quality of Life; Radiation Injuries; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate; Taxoids; Treatment Outcome | 2016 |
Dose-related fluorodeoxyglucose uptake in acute radiation-induced hepatitis.
Topics: Acute Disease; Antineoplastic Agents; Combined Modality Therapy; Docetaxel; Dose-Response Relationship, Radiation; Esophageal Neoplasms; Fluorodeoxyglucose F18; Hepatitis; Humans; Liver; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Taxoids | 2008 |
Comparison of the NCI-CTCAE version 4.0 and version 3.0 in assessing chemoradiation-induced oral mucositis for locally advanced nasopharyngeal carcinoma.
Topics: Adult; Antineoplastic Agents; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Quality of Life; Radiation Injuries; Radiation-Sensitizing Agents; Radiotherapy, Intensity-Modulated; Reproducibility of Results; Severity of Illness Index; Stomatitis; Surveys and Questionnaires; Taxoids; Treatment Outcome | 2012 |
Docetaxel and radiation-recall severe mucositis.
Topics: Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Small Cell; Docetaxel; Humans; Lung Neoplasms; Male; Mouth Mucosa; Paclitaxel; Radiation Injuries; Radiotherapy; Stomatitis; Taxoids | 1994 |
Highlights of the Eighth European Cancer Conference.
Topics: Amifostine; Antineoplastic Agents; Breast Neoplasms; Camptothecin; Colorectal Neoplasms; Combined Modality Therapy; Docetaxel; Head and Neck Neoplasms; Humans; Irinotecan; Neoplasms; Paclitaxel; Radiation Injuries; Radiation-Protective Agents; Taxoids; Vinblastine; Vinorelbine | 1995 |
Challenges in oncology. Case 2. Radiation recall associated with docetaxel.
Topics: Adult; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Ductal, Breast; Docetaxel; Female; Humans; Paclitaxel; Radiation Injuries; Radiotherapy; Skin; Taxoids | 2002 |